BridgeMD
New treatment option for Depression, Postpartum
Official title Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
ClinicalTrials.gov ID: NCT06877104
What this study is testing
- What it's testing
- The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
- Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
- Able to speak, read and write English
- Age ≥18
- Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
You likely can't join if
- Unable to provide informed consent
- Baby not discharged with mother at postpartum discharge
- Does not have access to a mobile phone
See the full eligibility criteria
- Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
- Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
- Able to speak, read and write English
- Age ≥18
- Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
- Completion of clinically administered EPDS during inpatient stay
- Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery
- Unable to provide informed consent
- Baby not discharged with mother at postpartum discharge
- Does not have access to a mobile phone
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.